News About: Pharm. Industry


Korea Bio Center to set up in Scotland in 2004.

According to the Korea Health Industry Development Institute (KHIDI) a biotech research center seems to be set up in Scotland under the name of "Korea Bio Center" in 2004 for the purpose of utilizing excellent bio rel...

Lilly Korea raises some questions over VA drug guideline

In line with the drug guideline released by the U.S. Veterans Affairs Medical Center that Zyprexa (olanzapine), an anti-psychotic medication, should be designated as the third-line drug, Lilly Korea has complained abo...

Overheated sales in eye preparations

With the rapid spread of conjunctivitis, called in Korea the "Apollo eye disease", some pharmaceutical firms are boasting their full operation ratio in factory to meet the domestic demand for ophthalmic agents in situ...

Delayed listing of new drugs into medical insurance drugs

Domestic pharmaceutical firms are experiencing much difficulties in their marketing activities due to the prolonged grant period of medical insurance price for new drugs ranging from 150 days to 300 days, pharmaceutic...

Keunwha Pharm faces government review for merger conditions

The M&A agreement executed between Sanofi-Synthelabo and Keunwha Pharm on July 29 this year may be nullified due to the transaction method. In its reply to a question raised by Keunwha Pharm, the National Tax Serv...

American VA medical center recommends risperidone as first-line anti-psychotic drug

The U.S. Veterans Affairs (VA) medical center announced its own drug guideline for schizophrenia, recommending that Risperdal (risperidone) and Seroquel be used as the first-line anti-psychotic medications and Zyprexa...

KPMA moving to abolish unified drug distribution channel.

The Korea Pharmaceutical Manufacturers Association (KPMA) is positively moving up to abolish the unified drug distribution channel system in an attempt to minimize possible damages caused by the implementation of the ...

Bioventure firms suffered insufficient number of R&D personnel

Bioventure businesses have suffered from a shortage of R&D and marketing personnel with worsened financial conditions, according to a survey conducted on 600 bioventure firms in Korea by the Korea Bioventure Associati...

Korea on top 3rd in world patent registration.

Korea has ranked the top 3rd in the world for the world patent registration with the total 73,378 cases according to the latest world statistics reported by the WIPO (World Industrial Property Organization). Then, num...

Roche sells Vitamins and Fine Chemicals Division to DSM

Roche and the Dutch Life Science company DSM NV announced on September 3 that DSM intends to acquire Roche's Vitamins and Fine Chemical Divisions. Roche said that the acquisition is part of its strategy aiming to f...

Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.